Search research articles
Contact Us
Filters
Showing results (1-10 of 52) with videos related to
Page
of 6
Sort By:
Neuron
|
July 19, 2002
Protein misfolding, amyloid formation, and neurodegeneration: a critical role for molecular chaperones?
Paul J Muchowski
Genome Biology
|
March 19, 2005
Connecting the dots in Huntington's disease with protein interaction networks
Flaviano Giorgini, Paul J Muchowski
Methods in Molecular Biology (Clifton, N.J.)
|
June 13, 2009
Exploiting yeast genetics to inform therapeutic strategies for Huntington's disease
Flaviano Giorgini, Paul J Muchowski
Methods in Enzymology
|
October 19, 2006
Screening for genetic modifiers of amyloid toxicity in yeast
Flaviano Giorgini, Paul J Muchowski
Neuromolecular Medicine
|
October 7, 2003
Making yeast tremble: yeast models as tools to study neurodegenerative disorders
Michael Y Sherman, Paul J Muchowski
Journal of Molecular Neuroscience : MN
|
May 6, 2004
Molecular genetics approaches in yeast to study amyloid diseases
Tiago Fleming Outeiro, Paul J Muchowski
Nature Reviews. Neuroscience
|
December 22, 2004
Modulation of neurodegeneration by molecular chaperones
Paul J Muchowski, Jennifer L Wacker
Journal of Huntington'S Disease
|
October 26, 2012
Genetic Deficiency of Complement Component 3 Does Not Alter Disease Progression in a Mouse Model of Huntington's Disease
Paul B Larkin, Paul J Muchowski
Structure (London, England : 1993)
|
September 15, 2009
Polyglutamine dances the conformational cha-cha-cha
Jason Miller, Earl Rutenber, Paul J Muchowski
Progress in Neurobiology
|
April 28, 2009
Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington's disease
Robert Schwarcz, Paolo Guidetti, Korrapati V Sathyasaikumar, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 52) with videos related to
Sort By:
Page
of 6
Neuron
|
July 19, 2002
Protein misfolding, amyloid formation, and neurodegeneration: a critical role for molecular chaperones?
Paul J Muchowski
Genome Biology
|
March 19, 2005
Connecting the dots in Huntington's disease with protein interaction networks
Flaviano Giorgini, Paul J Muchowski
Methods in Molecular Biology (Clifton, N.J.)
|
June 13, 2009
Exploiting yeast genetics to inform therapeutic strategies for Huntington's disease
Flaviano Giorgini, Paul J Muchowski
Methods in Enzymology
|
October 19, 2006
Screening for genetic modifiers of amyloid toxicity in yeast
Flaviano Giorgini, Paul J Muchowski
Neuromolecular Medicine
|
October 7, 2003
Making yeast tremble: yeast models as tools to study neurodegenerative disorders
Michael Y Sherman, Paul J Muchowski
Journal of Molecular Neuroscience : MN
|
May 6, 2004
Molecular genetics approaches in yeast to study amyloid diseases
Tiago Fleming Outeiro, Paul J Muchowski
Nature Reviews. Neuroscience
|
December 22, 2004
Modulation of neurodegeneration by molecular chaperones
Paul J Muchowski, Jennifer L Wacker
Journal of Huntington'S Disease
|
October 26, 2012
Genetic Deficiency of Complement Component 3 Does Not Alter Disease Progression in a Mouse Model of Huntington's Disease
Paul B Larkin, Paul J Muchowski
Structure (London, England : 1993)
|
September 15, 2009
Polyglutamine dances the conformational cha-cha-cha
Jason Miller, Earl Rutenber, Paul J Muchowski
Progress in Neurobiology
|
April 28, 2009
Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington's disease
Robert Schwarcz, Paolo Guidetti, Korrapati V Sathyasaikumar, et al.
Page
of 6